JP MORGAN/CALL/ELI LILLY & CO/1000/0.01/17.01.25 | Market Closed - Bid/Ask 03:42:09 27/06/2024 pm IST | After market 12:16:06 am | |||
| 0.57 EUR | +11.76% |
|
0.565 | -0.88% |
| Current month | +59.38% | ||
| 1 month | +64.52% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 27/24/27 | 0.57 | +11.76% |
| 25/24/25 | 0.51 | +2.00% |
| 24/24/24 | 0.5 | +2.04% |
| 21/24/21 | 0.49 | -3.92% |
| 20/24/20 | 0.51 | -3.77% |
Delayed Quote Börse Stuttgart
Last update June 27, 2024 at 03:42 pm IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | J.P. Morgan |
| WKN | JK2EYL |
| ISIN | DE000JK2EYL1 |
| Date issued | 08/02/2024 |
| Strike | 1,000 $ |
| Maturity | 17/01/2025 (204 Days) |
| Parity | 100 : 1 |
| Emission price | 0.17 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.57 € |
|---|---|
| Lowest since issue | 0.16 € |
| Delta | 0.43x |
| Omega | 6.418 |
| Premium | 17.2x |
| Gearing | 14.96x |
| Moneyness | 0.9049 |
| Difference Strike | 95.43 $ |
| Difference Strike % | +9.54% |
| Spread | 0.01 € |
| Spread % | 1.75% |
| Theoretical value | 0.5650 |
| Implied Volatility | 32.38 % |
| Total Loss Probability | 66.20 % |
| Intrinsic value | 0.000000 |
| Present value | 0.5650 |
| Break even | 1,060.49 € |
| Theta | -0.02x |
| Vega | 0.02x |
| Rho | 0.02x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
901.3
USD
Average target price
860.5
USD
Spread / Average Target
-4.52%
- Stock Market
- Warrants
- Warrant
